CD8A and colon adenocarcinoma: We applied JP in the anti-PD-L1 treatment against murine colon adenocarcinoma and determined the concentration of SCFAs, as well as the infiltration of CD8+ and CD8+INFγ+ in the microenvironment of tumor cells.